These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Combination sulfonylurea and insulin therapy in non-insulin-dependent diabetes mellitus. Collo MB; Johnson JL; Kabadi UM Nurse Pract; 1993 Jul; 18(7):40, 43-4, 47-8. PubMed ID: 8351085 [TBL] [Abstract][Full Text] [Related]
23. Oral antidiabetic agents: current role in type 2 diabetes mellitus. Krentz AJ; Bailey CJ Drugs; 2005; 65(3):385-411. PubMed ID: 15669880 [TBL] [Abstract][Full Text] [Related]
24. Management of the adult onset diabetic with sulfonylurea drug failure. Genuth S Endocrinol Metab Clin North Am; 1992 Jun; 21(2):351-70. PubMed ID: 1612070 [TBL] [Abstract][Full Text] [Related]
25. Combining insulin and oral agents in diabetes: indications and controversies. Rosenthal TC Am Fam Physician; 1992 Dec; 46(6):1721-7. PubMed ID: 1456195 [TBL] [Abstract][Full Text] [Related]
26. Insulin versus insulin plus sulfonylureas in type 2 diabetic patients with secondary failure to sulfonylureas. Scheen AJ; Lefèbvre PJ Diabetes Res Clin Pract; 1989 May; 6(4):S33-42; discussion S42-3. PubMed ID: 2666061 [TBL] [Abstract][Full Text] [Related]
27. Oral hypoglycemic agents in type II diabetes mellitus. Lubbos H; Miller JL; Rose LI Am Fam Physician; 1995 Nov; 52(7):2075-8. PubMed ID: 7484707 [TBL] [Abstract][Full Text] [Related]
28. Glimepiride. A review of its use in the management of type 2 diabetes mellitus. Langtry HD; Balfour JA Drugs; 1998 Apr; 55(4):563-84. PubMed ID: 9561345 [TBL] [Abstract][Full Text] [Related]
29. The acute and chronic effects of sulfonylurea therapy in type II diabetic subjects. Kolterman OG; Gray RS; Shapiro G; Scarlett JA; Griffin J; Olefsky JM Diabetes; 1984 Apr; 33(4):346-54. PubMed ID: 6423429 [TBL] [Abstract][Full Text] [Related]
30. Effect of sulfonylurea withdrawal on proinsulin levels, B cell function, and glucose disposal in subjects with noninsulin-dependent diabetes mellitus. Prigeon RL; Jacobson RK; Porte D; Kahn SE J Clin Endocrinol Metab; 1996 Sep; 81(9):3295-8. PubMed ID: 8784086 [TBL] [Abstract][Full Text] [Related]
31. Longitudinal evaluation of the effects of sulfonylurea therapy in subjects with type II diabetes mellitus. Kolterman OG Am J Med; 1985 Sep; 79(3B):23-33. PubMed ID: 3931459 [TBL] [Abstract][Full Text] [Related]
32. Relative hyperproinsulinemia of NIDDM persists despite the reduction of hyperglycemia with insulin or sulfonylurea therapy. Rachman J; Levy JC; Barrow BA; Manley SE; Turner RC Diabetes; 1997 Oct; 46(10):1557-62. PubMed ID: 9313749 [TBL] [Abstract][Full Text] [Related]
33. [Combination therapy with sulfonylurea plus insulin in "secondary failure" of type 2 diabetes]. Lotz N Ther Umsch; 1990 Jan; 47(1):49-54. PubMed ID: 2408182 [TBL] [Abstract][Full Text] [Related]
34. [Therapeutic management of the secondary failure of sulfonylurea therapy]. Sauer H Dtsch Med Wochenschr; 1985 Jan; 110(1):27-30. PubMed ID: 3880697 [No Abstract] [Full Text] [Related]
35. Choice of treatment affects plasma levels of insulin-like growth factor-binding protein-1 in noninsulin-dependent diabetes mellitus. Gibson JM; Westwood M; Crosby SR; Gordon C; Holly JM; Fraser W; Anderson C; White A; Young RJ J Clin Endocrinol Metab; 1995 Apr; 80(4):1369-75. PubMed ID: 7536208 [TBL] [Abstract][Full Text] [Related]
36. Pioglitazone and sulfonylureas: effectively treating type 2 diabetes. Hanefeld M Int J Clin Pract Suppl; 2007 Jun; 61(153):20-7. PubMed ID: 17594390 [TBL] [Abstract][Full Text] [Related]
37. Pharmacologic therapy for type 2 diabetes mellitus. DeFronzo RA Ann Intern Med; 1999 Aug; 131(4):281-303. PubMed ID: 10454950 [TBL] [Abstract][Full Text] [Related]
38. The management of non-insulin-dependent diabetes mellitus in the elderly. Ruoff G J Fam Pract; 1993 Mar; 36(3):329-35. PubMed ID: 8454981 [TBL] [Abstract][Full Text] [Related]